Analysen von Marc Goodman

31.01.18 Pfizer buy UBS AG
06.12.17 Pfizer buy UBS AG
21.12.12 Bausch Health kaufen UBS AG
12.12.12 Teva Pharmaceutical Industries neutral UBS AG
10.12.12 Bristol-Myers Squibb neutral UBS AG
03.12.12 Teva Pharmaceutical Industries neutral UBS AG
12.11.12 Merck buy UBS AG
05.11.12 Bausch Health buy UBS AG
02.11.12 Pfizer buy UBS AG
02.11.12 Teva Pharmaceutical Industries buy UBS AG
01.11.12 Allergan buy UBS AG
29.10.12 Merck buy UBS AG
15.10.12 Merck buy UBS AG
11.10.12 Teva Pharmaceutical Industries buy UBS AG
09.10.12 Eli Lilly neutral UBS AG
01.10.12 Eli Lilly neutral UBS AG
01.10.12 Bausch Health buy UBS AG
07.09.12 Warner Chilcott buy UBS AG
30.08.12 Teva Pharmaceutical Industries buy UBS AG
28.08.12 Eli Lilly neutral UBS AG
07.08.12 Pfizer buy UBS AG
06.08.12 Teva Pharmaceutical Industries buy UBS AG
06.08.12 Bausch Health buy UBS AG
02.08.12 Allergan buy UBS AG
03.08.12 Bristol-Myers Squibb neutral UBS AG
01.08.12 Pfizer buy UBS AG
26.07.12 Bristol-Myers Squibb neutral UBS AG
20.07.12 Pfizer buy UBS AG
20.07.12 Bristol-Myers Squibb neutral UBS AG
18.07.12 Pfizer buy UBS AG
13.07.12 Endo Health Solutions buy UBS AG
12.07.12 Merck buy UBS AG
25.06.12 Teva Pharmaceutical Industries buy UBS AG
22.06.12 Bausch Health buy UBS AG
06.06.12 Royal Caribbean Cruises buy UBS AG
06.06.12 Allergan buy UBS AG
25.05.12 Teva Pharmaceutical Industries buy UBS AG
10.05.12 Teva Pharmaceutical Industries buy UBS AG
10.05.12 Pfizer buy UBS AG
03.05.12 Pfizer buy UBS AG
23.04.12 Teva Pharmaceutical Industries buy UBS AG
19.04.12 Bausch Health buy UBS AG
23.03.12 Actavis buy UBS AG
06.03.12 Teva Pharmaceutical Industries buy UBS AG
23.02.12 Pfizer buy UBS AG
16.02.12 Teva Pharmaceutical Industries buy UBS AG
15.12.11 Merck buy UBS AG
13.12.11 Pfizer buy UBS AG
01.12.11 Teva Pharmaceutical Industries buy UBS AG
17.11.11 Pfizer buy UBS AG